Submits comments on the agency's new regulatory authority over tobacco
The AACR Task Force on Tobacco and Cancer recently prepared and submitted comments to the U.S. Food and Drug Administration (FDA) on the implementation of the historic Family Smoking Prevention and Tobacco Control Act (FSPTCA).
Given that tobacco use has been definitively proven to cause cancer and accounts for 30 percent of cancer mortality in the U.S., the AACR has a keen interest in strategic priorities that the FDA will pursue under the new regulatory authority over tobacco products granted by the FSPTCA.
The AACR Task Force on Tobacco and Cancer was convened to foster scientific and policy initiatives to reduce the incidence of disease and mortality due to tobacco use. As the FDA implements the FSPTCA, this task force will continue to provide its expertise and assistance, in addition to working on other initiatives to help eliminate tobacco use.
Read more from the October 2009 Edition of the AACR Cancer Policy Monitor: